Directori de persones
Montserrat Rué Monné

Montserrat Rué Monné

Grau: Doctor/a

973 702 441
montserrat.rue(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-5663-2009

Grups

Publicacions

  • Dalton, VK; Rue, M; Silverman, LB; Gelber, RD; Asselin, BL; Barr, RD; Clavell, LA; Hurwitz, CA; Moghrabi, A; Samson, Y; Schorin, M; Tarbell, NJ; Sallan, SE; Cohen, LE

    Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.

    Journal of Clinical Oncology 21 2953-2960. .

    [doi:10.1200/JCO.2003.03.068]

  • Hwang, SS; Chang, VT; Rue, M; Kasimis, B

    Multidimensional independent predictors of cancer-related fatigue.

    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT 26 604-614. .

    [doi:10.1016/S0885-3924(03)00218-5]

  • Bendell, JC; Domchek, SM; Burstein, HJ; Harris, L; Younger, J; Kuter, I; Bunnell, C; Rue, M; Gelman, R; Winer, E

    Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

    CANCER 97 2972-2977. .

    [doi:10.1002/cncr.11436]

  • Saas-Torres, J; Domingo, C; Moron, A; Rue, M; Marin, A

    Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.

    RESPIRATORY MEDICINE 97 599-605. .

    [doi:10.1053/rmed.2003.1486]

  • Fonseca, R; Blood, E; Rue, M; Harrington, D; Oken, MM; Kyle, RA; Dewald, GW; Van Ness, B; Van Wier, SA; Henderson, KJ; Bailey, RJ; Greipp, PR

    Clinical and biologic implications of recurrent genomic aberrations in myeloma

    Blood 101 4569-4575. .

    [doi:10.1182/blood-2002-10.3017]

  • Schnoll, RA; Zhang, B; Rue, M; Krook, JE; Spears, WT; Marcus, AC; Engstrom, PF

    Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group.

    Journal of Clinical Oncology 21 355-365. .

    [doi:10.1200/JCO.2003.04.122]

  • Signoretti, S; Di Marcotullio, L; Richardson, A; Ramaswamy, S; Isaac, B; Rue, M; Monti, F; Loda, M; Pagano, M

    Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

    JOURNAL OF CLINICAL INVESTIGATION 110 633-641. .

    [doi:10.1172/JCI200215795]

  • Rue, M; Roque, M; Sola, J; Macia, M

    Probabilistic models of mortality for patients admitted in conventional hospital units

    MEDICINA CLINICA 117 326-331. .

  • Cots Paltor I; Mimó Callís R; Grau Corominas M; Antoni Vives J; Rue M

    Episiotomía y puerperio domiciliario.

    Revista De Enfermería (barcelona, Spain) 24 461-463. .

  • Jornet, AR; Garcia, MG; Hernando, P; Vaca, JR; Padilla, J; Ponz, E; Almirall, J; Rue, M; Ocana, JCM; Yuste, E; Canellas, M; Ciurana, JM; Royo, C; Moreno, SG

    Voluntary discontinuation of dialysis

    Nefrologia 21 150-159. .

  • Rue, N; Quintana, S; Alvarez, M; Artigas, A

    Daily assessment of severity of illness and mortality prediction for individual patients.

    Critical Care Medicine 29 45-50. .

  • Rodriguez-Carballeira, M; Heredia, JL; Rue, M; Quintana, S; Gomez, L

    The bronchodilator test with increasing doses of terbutaline in chronic obstructive pulmonary disease patients.

    Pulmonary Pharmacology & Therapeutics 14 61-65. .

    [doi:10.1006/pupt.2000.0272]

Projectes

  • Liquid biopsies for the identification of mechanisms of resistance to PARP inhibitors in BRCA1/2-associated cancers
  • Personalización del cribado del cáncer de mama: Evaluación de su viabilidad y aceptabilidad en el Sistema Nacional de Salud
  • PARTICIPACION DE LAS MUJERES EN LAS DECISIONES Y ESTRATEGIAS DE DETECCION PRECOZ DEL CANCER DE MAMA
  • OPTIMITZACIO DELS PROGRAMES DE CRIBRATGE POBLACIONAL MITJAÇANT MODELS MATEMATICS: APLICACIO AL CRIBRATGE DEL CANCER DE MAMA
  • Optimización de los programas de cribado poblacional mediante modelos matemáticos: aplicación al cribado del cáncer de mama en España
  • Anàlisi de les diferències en la despesa farmacèutica i en la utilització de fàrmacs en la població immigrant i autòctona de la ciutat de Lleida